HLA-DPB1*0501-associated opticospinal multiple sclerosis. Clinical, neuroimaging and immunogenetic studies

Brain

Volumn 122, Issue 9, 1999, Pages 1689-1696

  Yamasaki, Kenji ^b   Horiuchi, Izumi ^b   Minohara, Motozumi ^b   Kawano, Yuji ^b   Ohyagi, Yasumasa ^b   Yamada, Takeshi ^b   Mihara, Futoshi ^b   Ito, Hiroshi ^b   Nishimura, Yasuharu ^b   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

Asians; Human leucocyte antigen; MRI; Multiple sclerosis

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; HLA DP ANTIGEN; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN; BRAIN STEM; CEREBELLUM; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEURORADIOLOGY; ONSET AGE; OPTIC NERVE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SPINAL CORD; SPINAL CORD ATROPHY;

EID: 0032883031     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.9.1689     Document Type: Article

References (25)

1. Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system. Hum Immunol 1994; 41: 1-20.
2. Ciusani E, Allen M, Sandberg-Wollheim M, Eoli M, Salmaggi A, Milanese C, et al. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients. Eur J Immunogenet 1995; 22: 171-8.
3. Dekker JW, Easteal S, Jakobsen IB, Gao X, Stewart GJ, Buhler MM, et al. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1 *0602 allele. Tissue Antigens 1993; 41: 31-6.
4. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991: Proceedings of the 11th International Histocompatibility Workshop and Conference, Vol. 1. Oxford: Oxford University Press; 1992. p. 1065-220.
5. Ito H, Yamasaki K, Kawano Y, Horiuchi I, Yun C, Nishimura Y, et al. HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 1998; 52: 179-82.
6. Kimura A, Sasazuki T. 11th International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991 : Proceedings of the 11th International Histocompatibility Workshop and Conference, Vol 1. Oxford: Oxford University Press; 1992. p. 397-419.
7. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569-74.
8. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T. Nationwide survey of multiple sclerosis in Japan: clinical analysis of 1,084 cases. Neurology 1975; 25: 845-51.
9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
10. Ma JJ, Nishimura M, Mine H, Saji H, Ohta M, Saida K, et al. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis. J Neuroimmunol 1998; 92: 109-12.
11. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-8.
12. Middleton D, Savage DA, Cullen C, Trainor F, Mallon E, Hawkins S. Frequency of HLA-DPB1 alleles in multiple sclerosis patients from Northern Ireland. Eur J Immunogenet 1992; 19: 323-6.
13. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. [Review]. Tissue Antigens 1991; 38: 1-15.
14. Ono T, Zambenedetti MR, Yamasaki K, Kawano Y, Ito H, Kamikawaji N, et al. Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). Tissue Antigens. In press 1999.
15. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DPE, Thompson EJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996; 60: 382-7.
16. Paty DW, Blume WT, Brown WF, Jaatoul N, Kertesz A, McInnis W. Chronic progressive myelopathy: investigation with CSF electrophoresis, evoked potentials, and CT scan. Ann Neurol 1979; 6: 419-24.
17. Poser S, Herrmann-Gremmels I, Wikström J, Poser W. Clinical features of the spinal form of multiple sclerosis. Acta Neurol Scand 1978; 57: 151-8.
18. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
19. Roth M-P, Coppin H, Descoins P, Ruidavets J-B, Cambon-Thomsen A, Clanet M. HLA-DPB1 gene polymorphism and multiple sclerosis: a large case-control study in the southwest of France. J Neuroimmunol 1991; 34: 215-22.
20. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981; 49: 253-71.
21. Spurkland A, Rønningen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 1991; 30: 69-75.
22. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53-62.
23. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-3.
24. Yu M, Kinkel RP, Weinstock-Guttman B, Cook DJ, Tuohy VK. HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum Immunol 1998; 59: 15-24.
25. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 27-30.